PATENT CLAIM ANALYSIS

Application Number: 16235524
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-07
Patent Classification: ["514", "235200"]

Abstract:
The invention relates to methods of reducing the level of 2-hydroxyglutarate in cells by administration of an inhibitor of mutant isocitrate dehydrogenase-1.

Claim (Index 9):
The method of  claim 1 , wherein the 2-HG producing cells comprise a mutation in mt isocitrate dehydrogenase-2 (IDH2) at residues 140 or 172.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 98.0
- Lexical Diversity: 1.15
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15964844', '15712446', '14858165', '15568051', '14858159']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7842112362700039
- 35 USC 102 Novelty (BERT): 0.5273219443162297
- Combined Prediction Score: 0.7585223070746265
- Mean Citation Score: 313.153344
- Max Citation Score: 326.39804
- Similarity Product: 207.3478866636944

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test